Financial Year |
March 31 2023 |
Monetary Funds |
1,263,116,404.42 |
Held-for-trading Financial Assets |
155,885,754.72 |
Notes Receivable |
799,288.50 |
Accounts Receivable |
39,091,877.69 |
Advances to Suppliers |
54,647,953.24 |
Other Receivables |
4,696,971.42 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
66,491,595.10 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
14,815,853.39 |
Total Current Assets |
1,600,273,261.88 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
272,052,253.25 |
Investment Properties |
113,765,776.95 |
Fixed Assetes |
41,626,964.97 |
Under-construction Projects |
-- |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
63,124,657.20 |
R&D expenses |
-- |
Goodwill |
132,619,611.85 |
Long-Term Deferred and Prepaid Expenses |
22,362,084.63 |
Deferred Income Tax Assets |
5,254,134.42 |
Other Non-Current Assets |
54,594,577.35 |
Sub-Total of Non-Current Assets |
1,201,967,651.42 |
Total Assets |
2,802,240,913.30 |
Short-Term Loans |
22,930,100.00 |
Trading Financial liabilities |
-- |
Notes Payable |
-- |
Accounts Payable |
1,921,678.57 |
Accounts Received In Advance |
21,654,215.69 |
Employee Compensation Payable |
11,465,204.27 |
Taxes Payable |
13,907,817.22 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
23,467,536.30 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
546,797.87 |
Other Current Liabilities |
4,229,308.50 |
Sub-Total of Current Liabilities |
132,655,739.56 |
Long-term Loans |
-- |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
55,605,027.86 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
56,424,612.70 |
Total Liabilities |
189,080,352.26 |
Paid-In Capital(Or Share Stock) |
528,000,000.00 |
Capital Surplus |
351,337,074.07 |
Surplus Reserve |
404,566,365.40 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
1,183,141,982.23 |
Minority Stockholder's Interest |
24,870,614.59 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,588,289,946.45 |
Owner's Equity(Stockholder's Equity) |
2,613,160,561.04 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
2,802,240,913.30 |